vimarsana.com

Page 8 - ஸ்காட் வழக்கறிஞர் இல் சட்டம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

State Street faces ERISA suit charging self-dealing

State Street faces ERISA suit charging self-dealing Print Participants in a $4.5 billion 401(k) plan sponsored by State Street Corp. have filed a class-action suit against the company, its subsidiaries and unnamed executives for alleged ERISA violations. The suit, filed Tuesday in federal court in Boston by Elizabeth Gomes and others on behalf of participants in the State Street Salary Savings Program, alleges that from May 25, 2015 to the present, State Street repeatedly and consistently selected investment funds managed by State Street or one of its subsidiaries for the plan over better-performing alternatives. The suit argues that the actions were done to financially benefit State Street to the detriment of the plan s performance and profitability, with State Street gaining more than $615 million in fees and other revenue and the plan to lose millions of dollars a year.

2nd Circuit Rules In Favor of Taro Pharmaceutical in Adverse Drug Effect Case

Health your username 6 days ago The Second Circuit on Tuesday affirmed a Southern District of New York dismissal of a case brought by 71 individuals against Taro Pharmaceutical U.S.A. Inc. lodging claims of strict liability, negligent failure to warn, negligent marketing and sale, negligence per se, fraud, and wrongful death stemming from the plaintiffs’ use of Taro drug Amiodarone. The original complaint against generic pharmaceutical manufacturer Taro alleged that the drug company was complicit in the injuries of the plaintiffs, some purportedly resulting in death, by failing to make “medication guides” noting proper use and risks of Amiodarone available to patients and failing to ensure that the drug information promulgated to physicians was accurate. The plaintiffs also claimed that Taro “concealed” records of adverse effects of the drug in treating atrial fibrillation.

Scott + Scott To Rep Precigen Investors In Gas Fraud Suit

ADVERTISEMENT ADVERTISEMENT Scott + Scott To Rep Precigen Investors In Gas Fraud Suit Law360 (April 8, 2021, 10:28 PM EDT) A federal judge in San Jose, California, on Thursday appointed Scott + Scott Attorneys at Law LLP to represent a proposed class of investors in biotechnology company Precigen Inc. in a suit alleging the company misrepresented aspects of a program aimed at converting methane into more valuable chemicals. In her order, U.S. District Judge Beth Labson Freeman named Scott + Scott lead counsel and designated the firm s client Raju Shah as lead plaintiff in the proposed class action, noting that among four movants, Shah s alleged losses of nearly $414,000, were the greatest claimed by an investor seeking to be lead plaintiff.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.